Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$11.64 +0.02 (+0.17%)
At close: Oct 23, 2026 · 4:00 PM EDT

Enanta Pharmaceuticals (ENTA) Sale and Maturity of Investments (2012 - 2026)

Updated

Analysis

Enanta Pharmaceuticals (ENTA) Sale and Maturity of Investments (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Enanta Pharmaceuticals 338.96 Mn -389.04 Mn - 39.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.52 Mn
Mar 31, 2026 53.91 Mn
Dec 31, 2025 101.47 Mn
Sep 30, 2025 72.38 Mn
Jun 30, 2025 59.66 Mn
Mar 31, 2025 53.19 Mn
Dec 31, 2024 77.65 Mn
Sep 30, 2024 28.02 Mn
Jun 30, 2024 95.35 Mn
Mar 31, 2024 125.58 Mn
Dec 31, 2023 134.52 Mn
Sep 30, 2023 119.32 Mn
Jun 30, 2023 33.05 Mn
Mar 31, 2023 72.40 Mn
Dec 31, 2022 104.10 Mn
Sep 30, 2022 38.40 Mn
Jun 30, 2022 54.55 Mn
Mar 31, 2022 26.75 Mn
Dec 31, 2021 108.77 Mn
Sep 30, 2021 72.12 Mn
API Access

Enanta Pharmaceuticals Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ENTA&period=max&api_key=YOUR_API_KEY